ARAY Stock Analysis: Buy, Sell, or Hold?
ARAY - Accuray Incorporated
$0.75
-0.05 (-6.20%)
▼
5d:
-8.95%
30d:
-11.44%
90d:
-46.69%
HOLD
LOW Confidence
Last Updated: February 3, 2026
Earnings: Feb 04, 2026
0d
Get Alerted When ARAY Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: ARAY shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
📊 HOLD: ARAY shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
In-depth Analysis How we analyze
Valuation Analysis: ARAY is currently trading at $0.75, which is considered oversold relative to its 30-day fair value range of $0.80 to $0.87. From a valuation perspective, the stock is trading at a discount (Forward PE: -25.1) compared to its historical average (39.3). At these levels, the market is pricing in 0% annual earnings growth.
Technical Outlook: Technically, ARAY is in a strong downtrend. Immediate support is located at $0.72, while resistance sits at $0.86. Short-term momentum is weak, with the stock down 6.2% recently.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $3.88 (+415.5%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, ARAY is in a strong downtrend. Immediate support is located at $0.72, while resistance sits at $0.86. Short-term momentum is weak, with the stock down 6.2% recently.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $3.88 (+415.5%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Fair Price Range
$0.80 -
$0.87
Company Quality Score
56/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
74.8%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (45/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-6.2%)
- BULLISH: Trading 415.5% below Wall St target ($3.88)
- CAUTION: Recommendation downgraded due to -9.0% 5-day decline
Fair Price Analysis
30-Day Fair Range
$0.80 -
$0.87
Current vs Fair Value
OVERSOLD
Support & Resistance Levels
Support Level
$0.72
Resistance Level
$0.86
Current Trend
Strong Downtrend
Fundamental Context
Forward P/E (Next Year Est.)
-25.06
Wall Street Target
$3.88
(+415.5%)
Revenue Growth (YoY)
16.8%
Earnings Growth (YoY)
-96.2%
Profit Margin
-4.3%
PE vs Historical
-25.1 vs 39.3
CHEAP
Last updated: February 04, 2026 7:25 AM ET
Data refreshes hourly during market hours. Next update: 8:25 AM
Data refreshes hourly during market hours. Next update: 8:25 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ARAY showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
STRONG BUY
34 analysts |
$124 | 60 HOLD |
|
SYK
Stryker Corporation |
BUY
32 analysts |
$424 | 67 BUY |
|
DXCM
DexCom Inc |
STRONG BUY
26 analysts |
$85 | 57 HOLD |
|
ABT
Abbott Laboratories |
BUY
28 analysts |
$134 | 62 BUY |
|
PODD
Insulet Corporation |
STRONG BUY
23 analysts |
$370 | 54 HOLD |
